Honkanen ILAs Flashcards
anti-cancer drugs inhibit _________
they don’t want DNA from cancer cell to replicate, so they want to inhibit stabilizing function of topoisomerase that would lead to supercoiling and then apoptosis
topoisomerase
remove acetyl group from chromatin, silencing gene expression
drugs that inhibit these are being tested for cancer treatment b/c they can allow silenced cancer cell to turn back on but then immediately stop proliferation and trigger apoptosis
histone deacetylases (HDACs)
distinguishes mRNA from other types of RNA and protects against degradation
7’ methyl guanosine cap
deficiency in this enzyme leads to low urea production and hyperammonemia (high levels of ammonia)
CPS I
deficiency in this enzyme will lead to defect in UMP and orotic aciduria; UTP inhibits this
CPS II (carbamoyl phosphate synthase II)
cancer drug that inhibits ribonucleotide reductase and treats sickle cell anemia
hydroxyurea
synthesis of deoxyribonucleotide depends on what; UDP to dUDP
ribonucleotide reductase
transcribes rRNA
RNA Pol I
transcribes mRNA
RNA Pol II
transcribes tRNA
RNA Pol III
what makes up nucleosomes that help stabilize DNA strand
histones
what breaks down into uric acid
purines
anti-cancer drug that inhibits ribonucleotide reductase (hydroxyurea inhibits this too)
gemcitabine
drug that stops breakdown of purine to uric acid
allopurinol
stops breakdown of purine to uric acid by inhibiting xanthine oxidase
allopurinol
uncompetitive inhibitor of IMP dehydrogenase
mycophenolate
deals with guanine and used to inhibit cellular immunity
mycophenolate
enzyme deficiency that leads to both Gout and Leysch-Nyhan syndrome
[these deal with purine synthesis]
HGPRT
this syndrome is caused by increase degradation of purines and large amounts of uric acid
leads to gout-like sx’s- buildup of uric acid (urate stones and crystals)
Leysch-Nyhan syndrome
this is caused by increased levels of uric acid in blood (hyperuricemia)
Gout
treatment for Gout (3 things)
[deals with purine synthesis]
NSAIDS
probenicid (uric acid excretion)
allopurinol (inhibits xanthine oxidase to stop purine into uric acid formation)
rate-limiting step (enzyme) of purine synthesis
amidotransferase
what promotes amidotransferase to make 5’ phosphoribosylamine
PRPP
what inhibits rate limiting enzyme (amidotransferase) of purine synthesis
IMP, AMP, and GMP, and 6’ mercaptopurine